Compared with patients without severe anemia, more patients developed severe anemia had a lower BMI, weight loss, a lower hemoglobin level, a lower platelet level, a higher serum creatinine level, a higher AST/ALT ratio, a lower sodium level, and an induction therapeutic dose of amphotericin B deoxycholate of > 0.58 mg/kg/d (Tables 1 and 2). The gene discussed is GPT; the disease is anemia (phenotype).